Trial Reporting and the Clinical Trials Enterprise-Reference-Cited by-同舟云学术

Trial Reporting and the Clinical Trials Enterprise

Published:2021-08-01 Issue:8 Volume:181 Page:1131
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Zarin Deborah A.¹,Califf Robert M.²

Affiliation:

1. Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, Cambridge, Massachusetts

2. Verily Life Sciences and Google Health, South San Francisco, California

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2780023/jamainternal_zarin_2021_il_210007_1627675028.78697.pdf

Reference10 articles.

1. Evaluation of compliance with legal requirements under the FDA Amendments Act of 2007 for timely registration of clinical trials, data verification, delayed reporting, and trial document submission.;DeVito;JAMA Intern Med

2. Update on trial registration 11 years after the ICMJE policy was established.;Zarin;N Engl J Med,2017

3. 10-Year update on study results submitted to ClinicalTrials.gov.;Zarin;N Engl J Med,2019

4. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.;Ross;BMJ,2012

5. Clinical trial registration and reporting: a survey of academic organizations in the United States.;Mayo-Wilson;BMC Med,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trial Registries, Results Databases, and Research Data Repositories;Health Informatics;2023

2. Responsible Conduct of Research (RCR) Instruction Supporting Research Integrity;Reconstructing Research Integrity;2023

3. Diversity and transparency in gynecologic oncology clinical trials;Cancer Causes & Control;2022-10-25

4. US drug regulator issues its first ever non-compliance notice for not posting trial results;BMJ;2021-05-28